Clinical Trials Browser

Phase 2 × maltodextrin × Gastrointestinal × Clear all

NCT03908255 2022-01-28

BCAA in HCC

Phase 2 Withdrawn

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition